Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Genetic risk for alcoholic chronic pancreatitis.

da Costa MZ, Guarita DR, Ono-Nita SK, Paranagu√°-Vezozzo DC, Felga GE, Pedroso MR, de Souza MM, Nasser PD, Ferreira Cda S, Carrilho FJ.

Int J Environ Res Public Health. 2011 Jul;8(7):2747-57. doi: 10.3390/ijerph8072747. Epub 2011 Jun 30. Review.

2.

Is Gilbert syndrome a new risk factor for breast cancer?

Astolfi RH, Bugano DD, Francisco AA, de Souza MM, Ono-Nita SK, Baracat EC.

Med Hypotheses. 2011 Aug;77(2):162-4. doi: 10.1016/j.mehy.2011.03.047. Epub 2011 Jun 1.

PMID:
21636218
3.

[Health technology assessment: II. Cost effectiveness analysis].

Secoli SR, Nita ME, Ono-Nita SK, Nobre M.

Arq Gastroenterol. 2010 Oct-Dec;47(4):329-33. Portuguese.

4.

Clinical trials profile: professionals and sites.

Paschoale HS, Barbosa FR, Nita ME, Carrilho FJ, Ono-Nita SK.

Contemp Clin Trials. 2010 Sep;31(5):438-42. doi: 10.1016/j.cct.2010.06.002. Epub 2010 Jun 25.

PMID:
20601160
5.

[Health technology assessment: research methodology].

Nita ME, Secoli SR, Nobre M, Ono-Nita SK.

Arq Gastroenterol. 2009 Oct-Dec;46(4):252-5. Portuguese.

6.

Simultaneous quantitation of serum HBV DNA and HBeAg can distinguish between slow and fast viral responses to antiviral therapy in patients with chronic hepatitis B.

da Silva LC, Nova ML, Ono-Nita SK, Pinho JR, Sitnik R, Santos VA, Carrilho FJ.

Rev Inst Med Trop Sao Paulo. 2009 Sep-Oct;51(5):261-8.

7.

A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent.

Clemente CM, Carrilho FJ, Pinho JR, Ono-Nita SK, Da Silva LC, Moreira RC, Lemos MF, de Carvalho Mello IM.

J Gastroenterol. 2009;44(6):568-76. doi: 10.1007/s00535-009-0044-8. Epub 2009 Apr 16.

PMID:
19370306
8.

CFTR polymorphisms in patients with alcoholic chronic pancreatitis.

da Costa MZ, Guarita DR, Ono-Nita SK, Nogueira Jde A, Nita ME, Paranagu√°-Vezozzo DC, de Souza MT, do Carmo EP, Teixeira AC, Carrilho FJ.

Pancreatology. 2009;9(1-2):173-81. doi: 10.1159/000178889. Epub 2008 Dec 13.

PMID:
19077469
9.

Hepatitis C: facts in numbers.

Ono-Nita SK, Nita ME, Carrilho FJ.

Arq Gastroenterol. 2006 Apr-Jun;43(2):71-2. No abstract available.

10.

Searching for chronic hepatitis B patients in a low prevalence area--role of racial origin.

Ono-Nita SK, Carrilho FJ, Cardoso RA, Nita ME, da Silva LC.

BMC Fam Pract. 2004 Apr 13;5:7.

11.

p53 immunostaining pattern in Brazilian patients with hepatocellular carcinoma.

Alves VA, Nita ME, Carrilho FJ, Ono-Nita SK, Wakamatsu A, Lehrbach DM, de Carvalho MF, de Mello ES, Gayotto LC, da Silva LC.

Rev Inst Med Trop Sao Paulo. 2004 Jan-Feb;46(1):25-31. Epub 2004 Mar 29.

12.

High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.

da Silva LC, Bassit L, Ono-Nita SK, Pinho JR, Nishiya A, Madruga CL, Carrilho FJ.

J Gastroenterol. 2002;37(9):732-6.

PMID:
12375147
13.

Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Ono-Nita SK, Kato N, Shiratori Y, Carrilho FJ, Omata M.

Antimicrob Agents Chemother. 2002 Aug;46(8):2602-5.

14.

Molecular aspects of hepatic carcinogenesis.

Nita ME, Alves VA, Carrilho FJ, Ono-Nita SK, Mello ES, Gama-Rodrigues JJ.

Rev Inst Med Trop Sao Paulo. 2002 Jan-Feb;44(1):39-48. Review.

15.

Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.

Kato J, Kato N, Yoshida H, Ono-Nita SK, Shiratori Y, Omata M.

J Med Virol. 2002 Feb;66(2):187-99.

PMID:
11782927
16.

Current Options for the Therapy of Chronic Hepatitis B Infection.

Kioko Ono-Nita S, Kato N, Shiratori Y, Omata M.

Curr Infect Dis Rep. 2001 Apr;3(2):137-142.

PMID:
11286654

Supplemental Content

Loading ...
Support Center